Search
Have an existing account?
Sign In
Search Stock Profiles
Latest News
My Top Three Stocks Fueling the Space Age 🚀
I’ve always been fascinated by space… I grew up on Dune, 2001:…
How Retail Investors Outplayed Wall Street in April
Retail investors crushed it in April 2025 — buying when hedge funds…
The Auction Heard ‘Round Wall Street
Hey Folks, Jeff Bishop here, Around 1:00 ET yesterday, stock traders felt…
Consumers Are Scared, and That Means — Opportunity! The headlines have been impossible to miss: In 2025, consumer confidence has cratered. At his inauguration, President Trump promised…
Consumers Are Scared, and That Means — Opportunity! The headlines have been…
AMGN: Amgen – Buy or Sell This Biotech Bruiser?
Amgen (AMGN) is the biotech jungle’s hulking gorilla, stomping at $283.50 (TipRanks) with a $100 billion+ market cap as of…
REGN: Regeneron Pharmaceuticals – Buy or Sell This Biotech Brainiac?
Regeneron Pharmaceuticals (REGN) is the biotech jungle’s clever monkey, swinging at $730.30 (U.S. News) with a $103 billion market cap…
The Biotech Bonanza: A Wild Ride Through the Stock Market Jungle
Buckle up, folks, because the biotech stock market as of March 26, 2025, is a jungle gym of thrills, spills,…
